NEW COURT SURGERY — All Prescriptions & Medications — Page 3
Practice Code: J83055 | SWINDON, SN4 7AX
Showing results 101-150 of 567
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Methylprednisolone acetate | 529 | 574 | £1.8K | +358.1% ▲ |
| Methotrexate | 529 | 11.7K | £11.8K | +62.5% ▲ |
| Warfarin sodium | 520 | 22.1K | £814 | +10.3% ▲ |
| Mebeverine hydrochloride | 512 | 25.7K | £1.1K | +64.9% ▲ |
| Alogliptin | 511 | 9,830 | £8.9K | +101.5% ▲ |
| Pantoprazole | 501 | 17.0K | £805 | +82.3% ▲ |
| Co-careldopa (Carbidopa/levodopa) | 500 | 40.0K | £2.9K | +121.2% ▲ |
| Pravastatin sodium | 498 | 13.3K | £621 | +53.4% ▲ |
| Buprenorphine | 495 | 1,987 | £5.3K | +35.1% ▲ |
| Betamethasone valerate | 494 | 41.5K | £1.8K | +28.3% ▲ |
| Lactulose | 489 | 285.5K | £2.7K | +48.5% ▲ |
| Insulin glargine | 479 | 3,064 | £26.3K | +68.7% ▲ |
| Sumatriptan succinate | 477 | 4,804 | £15.2K | +34.7% ▲ |
| Bumetanide | 475 | 18.8K | £2.2K | +74.4% ▲ |
| Umeclidinium bromide/vilanterol | 473 | 522 | £16.1K | +142.6% ▲ |
| Rivaroxaban | 466 | 14.9K | £10.3K | -23.8% ▼ |
| 464 | 519 | £698 | +110.6% ▲ | |
| Tirzepatide | 460 | 462 | £44.6K | +136.8% ▲ |
| Other emollient preparations | 457 | 243.6K | £3.1K | -23.9% ▼ |
| Quinine sulfate | 455 | 11.6K | £1.8K | +57.2% ▲ |
| Diltiazem hydrochloride | 442 | 14.6K | £2.9K | +43.9% ▲ |
| Risperidone | 442 | 8,333 | £1.8K | +74.7% ▲ |
| Fluticasone furoate/vilanterol | 437 | 536 | £12.1K | +182.3% ▲ |
| Hydrocortisone | 433 | 14.3K | £2.3K | -3.4% ▼ |
| Bendroflumethiazide | 427 | 18.9K | £304 | -44.8% ▼ |
| Insulin aspart | 426 | 2,962 | £19.1K | +11.9% ▲ |
| Trimethoprim | 420 | 11.8K | £690 | +105.5% ▲ |
| 413 | 50.3K | £2.1K | +215.2% ▲ | |
| Fluticasone/umeclidinium/vilanterol | 412 | 441 | £18.6K | +75.7% ▲ |
| Latanoprost | 398 | 6,963 | £2.7K | -18.0% ▼ |
| 396 | 405 | £2.1K | +67.6% ▲ | |
| Sodium valproate | 369 | 62.9K | £4.9K | +16.0% ▲ |
| Desogestrel | 368 | 66.1K | £2.1K | -7.2% ▼ |
| Mesalazine (Systemic) | 356 | 31.6K | £17.1K | +48.6% ▲ |
| Empagliflozin | 345 | 7,963 | £9.9K | -44.9% ▼ |
| Co-beneldopa (Benserazide/levodopa) | 340 | 50.4K | £3.5K | +124.9% ▲ |
| Dihydrocodeine tartrate | 331 | 30.8K | £2.0K | +69.4% ▲ |
| Prochlorperazine maleate | 323 | 14.3K | £779 | +59.8% ▲ |
| Cyclizine hydrochloride | 317 | 16.0K | £560 | +96.5% ▲ |
| Perindopril erbumine | 316 | 11.7K | £1.0K | -40.5% ▼ |
| Memantine hydrochloride | 313 | 6,049 | £788 | -5.2% ▼ |
| Eplerenone | 310 | 5,992 | £762 | +16.9% ▲ |
| Felodipine | 308 | 8,995 | £925 | -48.1% ▼ |
| Anastrozole | 306 | 8,751 | £2.4K | +236.1% ▲ |
| Lorazepam | 305 | 5,700 | £736 | +114.0% ▲ |
| Nicorandil | 293 | 15.3K | £2.2K | +103.5% ▲ |
| Beclometasone dipropionate | 291 | 310 | £864 | +35.3% ▲ |
| 291 | 118.7K | £1.6K | +10.3% ▲ | |
| Timolol and bimatoprost | 289 | 4,419 | £4.6K | +90.4% ▲ |
| Loperamide hydrochloride | 288 | 22.3K | £649 | +23.7% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.